This augmentation is attributed to the mobilization of CD8+ T cells into the tumor, facilitated by the CXCL10/CXCR3 axis, mainly observed in hepatocellular carcinoma (HCC) [14]. This evidence concerns the gene CD8A and hepatocellular carcinoma.